Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
Conditions
- ALK Gene Rearrangement Positive
- Non-Squamous Non-Small Cell Neoplasm of Lung
Interventions
- DRUG: Alectinib
- DRUG: Bevacizumab
Sponsor
Instituto Nacional de Cancerologia de Mexico
Collaborators